IRIDEX Newsroom

Iridex Analyst Ratings

BenzingaMay 15 07:51 ET

Analysts Offer Insights on Healthcare Companies: Iridex (IRIX), Nyxoah (NYXH) and Enliven Therapeutics (ELVN)

TipRanksMay 15 07:06 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Argenx Se (ARGX), Iridex (IRIX) and Keros Therapeutics (KROS)

TipRanksMar 27 08:45 ET

Stifel Nicolaus Sticks to Its Hold Rating for Iridex (IRIX)

TipRanksMar 10, 2023 07:21 ET

Stifel Nicolaus Downgrades Iridex (IRIX) to a Hold

TipRanksAug 29, 2022 22:10 ET

Iridex Price Target Cut to $3.00/Share From $5.00 by Stifel

Dow JonesAug 26, 2022 06:20 ET

Iridex Cut to Hold From Buy by Stifel

Dow JonesAug 26, 2022 06:20 ET

Iridex Analyst Ratings

Benzinga Analyst RatingsAug 26, 2022 06:11 ET